337 related articles for article (PubMed ID: 34959070)
1. Downregulation of TREM2 expression exacerbates neuroinflammatory responses through TLR4-mediated MAPK signaling pathway in a transgenic mouse model of Alzheimer's disease.
Ruganzu JB; Peng X; He Y; Wu X; Zheng Q; Ding B; Lin C; Guo H; Yang Z; Zhang X; Yang W
Mol Immunol; 2022 Feb; 142():22-36. PubMed ID: 34959070
[TBL] [Abstract][Full Text] [Related]
2. TREM2 overexpression rescues cognitive deficits in APP/PS1 transgenic mice by reducing neuroinflammation via the JAK/STAT/SOCS signaling pathway.
Ruganzu JB; Zheng Q; Wu X; He Y; Peng X; Jin H; Zhou J; Ma R; Ji S; Ma Y; Qian Y; Wang Y; Yang W
Exp Neurol; 2021 Feb; 336():113506. PubMed ID: 33065077
[TBL] [Abstract][Full Text] [Related]
3. Imbalance of Microglial TLR4/TREM2 in LPS-Treated APP/PS1 Transgenic Mice: A Potential Link Between Alzheimer's Disease and Systemic Inflammation.
Zhou J; Yu W; Zhang M; Tian X; Li Y; Lü Y
Neurochem Res; 2019 May; 44(5):1138-1151. PubMed ID: 30756214
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of TREM2/DAP12 complex affecting β-amyloid plaque deposition in Alzheimer's disease modeled mice through mediating inflammatory response.
Cui X; Qiao J; Liu S; Wu M; Gu W
Brain Res Bull; 2021 Jan; 166():21-28. PubMed ID: 33053435
[TBL] [Abstract][Full Text] [Related]
5. Silencing of LRP1 Exacerbates Inflammatory Response Via TLR4/NF-κB/MAPKs Signaling Pathways in APP/PS1 Transgenic Mice.
He Y; Ruganzu JB; Zheng Q; Wu X; Jin H; Peng X; Ding B; Lin C; Ji S; Ma Y; Yang W
Mol Neurobiol; 2020 Sep; 57(9):3727-3743. PubMed ID: 32572761
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer's disease.
Jiang T; Tan L; Zhu XC; Zhang QQ; Cao L; Tan MS; Gu LZ; Wang HF; Ding ZZ; Zhang YD; Yu JT
Neuropsychopharmacology; 2014 Dec; 39(13):2949-62. PubMed ID: 25047746
[TBL] [Abstract][Full Text] [Related]
7. Triggering receptor expressed on myeloid cells 2 activation downregulates toll-like receptor 4 expression and ameliorates cognitive impairment in the Aβ
Qin Z; Gu M; Zhou J; Zhang W; Zhao N; Lü Y; Yu W
Synapse; 2020 Oct; 74(10):e22161. PubMed ID: 32412103
[TBL] [Abstract][Full Text] [Related]
8. TREM2 Overexpression has No Improvement on Neuropathology and Cognitive Impairment in Aging APPswe/PS1dE9 Mice.
Jiang T; Wan Y; Zhang YD; Zhou JS; Gao Q; Zhu XC; Shi JQ; Lu H; Tan L; Yu JT
Mol Neurobiol; 2017 Mar; 54(2):855-865. PubMed ID: 26780455
[TBL] [Abstract][Full Text] [Related]
9. Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease.
Melchior B; Garcia AE; Hsiung BK; Lo KM; Doose JM; Thrash JC; Stalder AK; Staufenbiel M; Neumann H; Carson MJ
ASN Neuro; 2010 Jul; 2(3):e00037. PubMed ID: 20640189
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of TREM2 Ameliorates Neuroinflammatory Responses and Improves Cognitive Deficits Triggered by Surgical Trauma in Appswe/PS1dE9 Mice.
Jiang Y; Li Z; Ma H; Cao X; Liu F; Tian A; Sun X; Li X; Wang J
Cell Physiol Biochem; 2018; 46(4):1398-1411. PubMed ID: 29689568
[TBL] [Abstract][Full Text] [Related]
11. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
[TBL] [Abstract][Full Text] [Related]
12. LRP1 knockdown aggravates Aβ
He Y; Ruganzu JB; Jin H; Peng X; Ji S; Ma Y; Zheng L; Yang W
Exp Cell Res; 2020 Sep; 394(2):112166. PubMed ID: 32645395
[TBL] [Abstract][Full Text] [Related]
13. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV
J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586
[No Abstract] [Full Text] [Related]
14. Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the
Shi Q; Chang C; Saliba A; Bhat MA
J Neurosci; 2022 Jul; 42(27):5294-5313. PubMed ID: 35672148
[TBL] [Abstract][Full Text] [Related]
15. Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice.
Fitz NF; Wolfe CM; Playso BE; Biedrzycki RJ; Lu Y; Nam KN; Lefterov I; Koldamova R
Mol Neurodegener; 2020 Jul; 15(1):41. PubMed ID: 32703241
[TBL] [Abstract][Full Text] [Related]
16. TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease.
Song M; Jin J; Lim JE; Kou J; Pattanayak A; Rehman JA; Kim HD; Tahara K; Lalonde R; Fukuchi K
J Neuroinflammation; 2011 Aug; 8():92. PubMed ID: 21827663
[TBL] [Abstract][Full Text] [Related]
17. p110δ PI3-Kinase Inhibition Perturbs APP and TNFα Trafficking, Reduces Plaque Burden, Dampens Neuroinflammation, and Prevents Cognitive Decline in an Alzheimer's Disease Mouse Model.
Martínez-Mármol R; Mohannak N; Qian L; Wang T; Gormal RS; Ruitenberg MJ; Vanhaesebroeck B; Coulson EJ; Meunier FA
J Neurosci; 2019 Oct; 39(40):7976-7991. PubMed ID: 31363064
[TBL] [Abstract][Full Text] [Related]
18. Bilateral intracerebroventricular injection of streptozotocin induces AD-like behavioral impairments and neuropathological features in mice: Involved with the fundamental role of neuroinflammation.
Fan M; Liu S; Sun HM; Ma MD; Gao YJ; Qi CC; Xia QR; Ge JF
Biomed Pharmacother; 2022 Sep; 153():113375. PubMed ID: 35834993
[TBL] [Abstract][Full Text] [Related]
19. Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice.
Sheng L; Chen M; Cai K; Song Y; Yu D; Zhang H; Xu G
FASEB J; 2019 Sep; 33(9):10425-10442. PubMed ID: 31219699
[TBL] [Abstract][Full Text] [Related]
20. TREM2 Attenuates Aβ1-42-Mediated Neuroinflammation in BV-2 Cells by Downregulating TLR Signaling.
Long H; Zhong G; Wang C; Zhang J; Zhang Y; Luo J; Shi S
Neurochem Res; 2019 Aug; 44(8):1830-1839. PubMed ID: 31134514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
